Email this article 
Epidemiology and Providing of Healthcare for Patients with Inherited Epidermolysis Bullosa in the Russian Federation
- Authors: Kubanov A.A.1, Karamova A.A.1, Chikin V.V.1, Bogdanova E.V.1, Monchakovskaya E.S.1
-
Affiliations:
- State Research Center of Dermatovenereology and Cosmetology, Ministry of Healthcare of the Russian Federation
- Issue: Vol 73, No 6 (2018)
- Pages: 420-430
- Section: PEDIATRICS: CURRENT ISSUES
- URL: https://vestnikramn.spr-journal.ru/jour/article/view/980
- DOI: https://doi.org/10.15690/vramn980
- ID: 980
Cite item
Full Text
Abstract
Background: Inherited epidermolysis bullosa is a group of genetic skin disorders. In most severe forms, such as junctional and dystrophic subtypes, quality of life and life expectancy are significantly decreased. Therapeutic approaches include wound care and complication treatment.
Aims: To evaluate the incidence and prevalence of inherited epidermolysis bullosa in the Russian Federation, sociodemographic characterisrics and provision of healthcare.
Methods: To conduct the research forms summarizing demographic, medical and social information on inherited epidermolysis bullosa patients were developed. The forms were sent to state outpatient dermatologic clinics in federal subject of the Russian Federation. Data on inherited epidermolysis bullosa patients from outpatient dermatologic clinics were obtained within the period of 2014−2016 by extracting information from their medical charts. A confirmed inherited epidermolysis bullosa diagnosis was considered as an inclusion criterion for the research. Based on the collected data prevalence and incidence rate were estimated.
Results: Data on 439 patients from 70 federal subject at year-end 2014, 404 patients from 59 federal subject at year-end 2015 and 417 patients from 60 federal subject at year-end 2016 were collected. In 2014 EB simplex was diagnosed in 19.6% patients, dystrophic EB — in 11.6% patients. In most patients (66%) EB type was not diagnosed. In 2016 patients with EB simplex (48%) and dystrophic EB (24.2%) prevailed. In 25% patients an EB type was not specified. In 2014 the prevalence rates were estimated as 3.6 (in 70 federal subject), in 2015 — 3.8 (in 59 federal subject), in 2016 — 3.9 per 1 million population (in 60 federal subject). The incidence rates were estimated as 0.22 and 0.33 per 1 million population in 2015 and 2016 respectively.
Conclusions: In 2016 the percent of patients with established EB type has increased in comparison to 2014. No significant changes in prevalence rates has been registered.
About the authors
Alexey A. Kubanov
State Research Center of Dermatovenereology and Cosmetology, Ministry of Healthcare of the Russian Federation
Email: alex@cnikvi.ru
ORCID iD: 0000-0002-7625-0503
MD, PhD, Professor
3 bld 6, Korolenko street, 107076 Moscow
SPIN-ID: 3604-6491
Russian Federation
Arfenya A. Karamova
State Research Center of Dermatovenereology and Cosmetology, Ministry of Healthcare of the Russian Federation
Author for correspondence.
Email: karamova@cnikvi.ru
ORCID iD: 0000-0003-3805-8489
MD, PhD.
Moscow
SPIN-ID: 3604-6491
Russian Federation
Vadim V. Chikin
State Research Center of Dermatovenereology and Cosmetology, Ministry of Healthcare of the Russian Federation
Email: chikin@cnikvi.ru
ORCID iD: 0000-0002-9688-2727
MD, PhD.
Moscow
SPIN-ID: 3385-4723
Russian Federation
Elena V. Bogdanova
State Research Center of Dermatovenereology and Cosmetology, Ministry of Healthcare of the Russian Federation
Email: bogdanova@cnikvi.ru
ORCID iD: 0000-0002-0662-2682
MD, PhD.
Moscow
SPIN-ID: 6372-2237
Russian Federation
Ekaterina S. Monchakovskaya
State Research Center of Dermatovenereology and Cosmetology, Ministry of Healthcare of the Russian Federation
Email: monchakovskaya@cnikvi.ru
ORCID iD: 0000-0002-6402-0962
MD.
Moscow
SPIN-ID: 9859-1912
Russian Federation
References
- Fine J. Inherited epidermolysis bullosa. Orphanet J Rare Dis. 2010;5:12. doi: 10.1186/1750-1172-5-12.
- Fine J, Bruckner-Tuderman L, Eady RA, et al. Inherited epidermolysis bullosa: updated recommendations on diagnosis and classification. J Am Acad Dermatol. 2014;70(6):1103–1126. doi: 10.1016/j.jaad.2014.01.903.
- Fine J, Mellerio J. Extracutaneous manifestations and complications of inherited epidermolysis bullosa: part I. Epithelial associated tissues. J Am Acad Dermatol. 2009;61(3):367–384. doi: 10.1016/j.jaad.2009.03.052.
- Fine J, Mellerio J. Extracutaneous manifestations and complications of inherited epidermolysis bullosa: part II. Other organs. J Am Acad Dermatol. 2009;61(3):387–402. doi: 10.1016/j.jaad.2009.03.053.
- Devries D, Johnson L, Weiner M, Fine J. Relative extent of skin involvement in inherited epidermolysis bullosa (EB): composite regional anatomic diagrams based on the findings of the National EB Registry, 1986 to 2002. J Am Acad Dermatol. 2004;50(4):572–581. doi: 10.1016/j.jaad.2003.09.026.
- Федеральные клинические рекомендации. Дерматовенерология 2015: Болезни кожи. Инфекции, передаваемые половым путем / Под ред. Кубановой А.А. — М.: Деловой экспресс; 2016. — 768 с.
- Hernandez-Martín A, Aranegui B, Escámez MJ, et al. Prevalence of dystrophic epidermolysis bullosa in Spain: a population-based study using the 3-source capture–recapture method. Evidence of a need for improvement in care. Actas Dermosifiliogr. 2013;104(10):890–896. doi: 10.1016/j.ad.2013.03.006.
- El Hachem M, Zambruno G, Bourdon-Lanoy E, et al. Multicentre consensus recommendations for skin care in inherited epidermolysis bullosa. Orphanet J Rare Dis. 2014;9(1):76. doi: 10.1186/1750-1172-9-76.
- Montaudié H, Chiaverini C, Sbidian E, et al. Inherited epidermolysis bullosa and squamous cell carcinoma: a systematic review of 117 cases. Orphanet J Rare Dis. 2016;11(1):117. doi: 10.1186/s13023-016-0489-9.
- Mallipeddi R. Epidermolysis bullosa and cancer. Clin Exp Dermatol. 2002;27(8):616–623. doi: 10.1046/j.1365-2230.2002.01130.x.
- Kim M, Murrell DF. Update on the pathogenesis of squamous cell carcinoma development in recessive dystrophic epidermolysis bullosa. Eur J Dermatol. 2015;25 Suppl 1:30–32. doi: 10.1684/ejd.2015.2552.
- Fine J, Johnson L, Weiner M, et al. Epidermolysis bullosa and the risk of life-threatening cancers: the National EB Registry experience, 1986–2006. J Am Acad Dermatol. 2009;60(2):203–211. doi: 10.1016/j.jaad.2008.09.035.
- Angelis A, Kanavos P, López-Bastida J, et al. Social/economic costs and health-related quality of life in patients with epidermolysis bullosa in Europe. Eur J Health Econ. 2016;17 Suppl 1:31–42. doi: 10.1007/s10198-016-0783-4.
- Pope E, Lara-Corrales I, Mellerio J, et al. A consensus approach to wound care in epidermolysis bullosa. J Am Acad Dermatol. 2012;67(5):904–917. doi: 10.1016/j.jaad.2012.01.016.
- Auvin S, Irwin J, Abi-Aad P, Battersby A. The problem of rarity: estimation of prevalence in rare disease. Value Health. 2018;21(5):501–507. doi: 10.1016/j.jval.2018.03.002.
- Fine JD. Epidemiology of inherited epidermolysis bullosa based on incidence and prevalence estimates from the National Epidermolysis Bullosa Registry. JAMA Dermatol. 2016;152(11):1231–1238. doi: 10.1001/jamadermatol.2016.2473.
- Kho YC, Rhodes LM, Robertson SJ, et al. Epidemiology of epidermolysis bullosa in the antipodes: the Australasian Epidermolysis Bullosa Registry with a focus on Herlitz junctional epidermolysis bullosa. Arch Dermatol. 2010;146(6):635–640. doi: 10.1001/archdermatol.2010.109.
- Dănescu S, Has C, Senila S, et al. Epidemiology of inherited epidermolysis bullosa in Romania and genotype-phenotype correlations in patients with dystrophic epidermolysis bullosa. J Eur Acad Dermatol Venereol. 2014;29(5):899–903. doi: 10.1111/jdv.12709.
- Horn H, Priestley G, Eady R, Tidman M. The prevalence of epidermolysis bullosa in Scotland. Br J Dermatol. 1997;136(4):560–564. doi: 10.1046/j.1365-2133.1997.d01-1235.x.
- McKenna K, Walsh M, Bingham E. Epidermolysis bullosa in Northern Ireland. Br J Dermatol. 1992;127(4):318–321. doi: 10.1111/j.1365-2133.1992.tb00448.x. doi: 10.1111/j.1365-2133.1992.tb00448.x.
- Pavicić Z, Kmet-Vizintin P, Kansky A, Dobrić I. Occurrence of hereditary bullous epidermolyses in Croatia. Pediatr Dermatol. 1990;7(2):108–110. doi: 10.1111/j.1525-1470.1990.tb00664.x.
- Кубанов А.А., Альбанова В.И., Карамова А.Э., и др. Распространенность врожденного буллезного эпидермолиза у населения Российской Федерации // Вестник дерматологии и венерологии. — 2015. — №3 — C. 21–30.
- Castiglia D, Zambruno G. Epidermolysis bullosa care in Italy. Dermatol Clin. 2010;28(2):407–409. doi: 10.1016/j.det.2010.02.016.
Supplementary files
